327. Oritavancin Activity against Staphylococcus aureus Isolates Causing Bone and Joint Infections in European Hospitals (2010–2019)

BACKGROUND: Bone and joint infections (BJI) frequently are caused by Staphylococcus aureus (SA), and since prolonged therapy courses typically are required, agents with convenient administration are preferred. Oritavancin (ORI) is a long-acting lipoglycopeptide approved as a single dose regimen for...

Descripción completa

Detalles Bibliográficos
Autores principales: Carvalhaes, Cecilia G, Streit, Jennifer M, Sader, Helio S, Mendes, Rodrigo E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Poster Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7776473/
http://dx.doi.org/10.1093/ofid/ofaa439.523

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7776473/
http://dx.doi.org/10.1093/ofid/ofaa439.523

Ejemplares similares